Cell culture inactivated influenza vaccines (Annex to note for guidance on harmonisation of requirements for influenza vaccines)

This document addresses the safety and efficacy issues, which are pertinent to cell culture inactivated influenza vaccines. It includes the issue of yearly strain changes, where relevant. It has been superseded by the guideline on influenza vaccines - quality module.

Keywords: Influenza vaccines, inactivated

Current effective version

Cell culture inactivated influenza vaccines - Annex to note for guidance on harmonisation of requirements for influenza vaccines CPMP/BWP/214/96

AdoptedLegal effective date: 31/08/2002Reference Number: CPMP/BWP/2490/00/Adopted

Document history

Concept paper on the development of a committee for proprietary medicinal products (CPMP) points to consider on on cell-derived influenza vaccines

Reference Number: CPMP/BWP/1764/99